A Phase III Superiority Study of Vernakalant vs Amiodarone in Subjects With Recent Onset Atrial Fibrillation - No Study Results Posted

A Phase III Superiority Study of Vernakalant vs Amiodarone in Subjects With Recent Onset Atrial Fibrillation (AVRO)

This study has been completed.

Study NCT00668759 Information provided by Cardiome Pharma

First Received: April 25, 2008 Last Updated: December 12, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	November 2009
Primary Completion Date:	October 2009 (Final data collection date for primary outcome measure)

No publications provided by Cardiome Pharma

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):